Filing Flows › InspireMD (NSPR) › Q1 2025
InspireMD (NSPR) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
InspireMD (NSPR) reported revenue of $1.5M for the first quarter 2025 (Q1 2025), +1% from a year earlier and -22% from the quarter before. Operating margin was -749.5%, net loss $11.2M (730.3% of revenue).
InspireMD, Q1 2025: revenue $1.5M (+1% year over year), operating margin -749.5%, net loss $11.2M, operating cash flow −$8.8M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | -22% | +1% |
| Operating profit | −$11.5M | — | — |
| Net earnings | −$11.2M | — | — |
| Operating cash flow | −$8.8M | — | — |
What changed
Revenue was $1.5M in Q1 2025, up 1% year over year and down 22% from the previous quarter.
Gross margin was 19.1%, down 0.2 points from a year earlier. Operating costs exceeded revenue by $11.5M, an operating margin of -749.5%. Operating expenses grew 53% against revenue growth of 1%. The fastest-growing cost line was Sales & marketing (+122%). The quarter ended with a net loss of $11.2M, wider than the previous quarter's $9.2M loss.
Operating cash flow was −$8.8M. Non-cash charges added back $98K of depreciation and $2.7M of share-based compensation. Working capital and other items used $453K. Capital expenditures of $359K exceeded it, leaving free cash flow of −$9.2M.
Questions
What was InspireMD's revenue in the first quarter 2025?
InspireMD (NSPR) reported revenue of $1.5M for the first quarter 2025 (Q1 2025), +1% from a year earlier and -22% from the quarter before.
Was InspireMD profitable in the first quarter 2025?
Operating loss was $11.5M (-749.5% of revenue) and net loss $11.2M.
Source: InspireMD 10-Q on SEC EDGAR.